Baird Financial Group, Inc. Procept Bio Robotics Corp Transaction History
Baird Financial Group, Inc.
- $50.4 Billion
- Q4 2024
A detailed history of Baird Financial Group, Inc. transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Baird Financial Group, Inc. holds 54,237 shares of PRCT stock, worth $3.44 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
54,237
Previous 38,910
39.39%
Holding current value
$3.44 Million
Previous $3.12 Million
40.1%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding PRCT
# of Institutions
295Shares Held
41.6MCall Options Held
196KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA5.14MShares$326 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$221 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.75MShares$111 Million0.05% of portfolio
-
Wellington Management Group LLP Boston, MA1.49MShares$94.5 Million0.02% of portfolio
-
Loomis Sayles & CO L P1.21MShares$76.5 Million0.12% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.83B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...